Vertias Pharma Inc
Description
A discovery & development company focused on scientifically finding new medicinal cannabis cultivars for specific disease conditions.
An alliance of:
Academic pharmacologists, anesthetists, chemists
Pharmaceutical industry specialists
Major medicinal marijuana producer
Professional financiers
Current State of Medicinal Cannabis and Related Products on the Market
Medicinal cannabis is not approved by many regulatory agencies such as the US FDA
Cannabis is varied and often lacking pharmaceutical grade QA/QC and solid scientific proof of effectiveness
Most insurance companies do not reimburse for marijuana based treatments
Few cannabis-based pharmaceuticals available and many have had limited success due their side effect profiles
Company’s Research Strategy
To chemically profile different cannabis cultivars
To pharmacologically profile those same cultivars in the search for disease specific strains
Clinical Trial Performance to Demonstrate Clinical Utility for Specific Disease Conditions:
Chronic Pain (e.g. cancer pain)
Nausea & Vomiting
Muscle Spasms
Epilepsy
Post-Traumatic Stress Disorder (PTSD)
Contact Us:
Veritas Pharma Inc
101 – 2386 East Mall
University of British Columbia
Vancouver, BC V6T 1Z3
Investor Relations Contact:
Sam Eskandari
T: +1 (416) 918-6785
E: ir@veritaspharmainc.com
Auditor Contact:
Saturna Group Chartered Accountants LLP
1250–1066 West Hastings St.
Vancouver, BC V6E 3X1
T: 604-630-5100
